Washington, D.C., February 23, 2026 — Scientists have uncovered a groundbreaking explanation for why residing at high altitudes appears to shield individuals from developing diabetes. Research indicates that when oxygen levels decrease, red blood cells activate a novel metabolic pathway, absorbing large amounts of glucose from the bloodstream and potentially reducing diabetes risk.
The discovery, published in Cell Metabolism, was made by researchers at Gladstone Institutes. Their findings suggest that in low-oxygen environments—such as high mountain regions—red blood cells behave like “sugar sponges,” helping the body manage blood sugar levels more effectively.
The Science Behind the Blood Moon of Metabolism
The team, led by senior author Isha Jain, PhD, a biochemist and investigator at the UC San Francisco-affiliated Arc Institute, explains that under hypoxic conditions, red blood cells adapt by altering their metabolism to enhance oxygen delivery to tissues. Simultaneously, they absorb substantial amounts of glucose, thus lowering circulating blood sugar levels.
“This discovery reveals a previously unappreciated role of red blood cells in glucose metabolism,” Jain stated. “They’re not just oxygen carriers—they act as a hidden glucose sink under low oxygen conditions.”
How It Works
The researchers found that when oxygen levels drop, red blood cells generate a molecule that facilitates oxygen release to tissues. This process also consumes glucose, effectively reducing blood sugar levels. In experiments with mice exposed to hypoxia, the animals showed significantly lower blood glucose levels, and their red blood cells absorbed more glucose compared to those under normal oxygen conditions.
Remarkably, the metabolic shift persisted for weeks after returning mice to normal oxygen levels, highlighting its lasting effects.
A New Potential Treatment for Diabetes
Building on this insight, the scientists developed a drug called HypoxyStat, which mimics the effects of high-altitude hypoxia. Taken as a pill, HypoxyStat causes hemoglobin in red blood cells to bind oxygen more tightly, limiting oxygen delivery to tissues. In diabetic mice, the drug completely reversed high blood sugar levels and outperformed existing treatments.
“This could revolutionize how we approach diabetes management,” Jain emphasized. “Instead of targeting insulin or glucose directly, we can harness red blood cells’ ability to absorb glucose.”
Broader Implications
Beyond diabetes, the findings could have implications for trauma care, exercise physiology, and conditions involving pathological hypoxia. The team believes this research opens new avenues for understanding how the body adapts to oxygen deprivation and how these mechanisms can be leveraged for therapeutic purposes.
As Jain concludes, “There’s still much to learn about how our bodies respond to low oxygen, and this discovery is just the beginning of a new frontier in medicine.”
